| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |